$JNJ's earnings are a good barometer for understanding how #COVID19 is impacting hospitals, particularly in the U.S.

Some elective surgeries are already resuming in China. “But it’s really going to depend on the pandemic itself,” J&amp;J's CFO said

https://t.co/OHQLnD7LkA